Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community;Évaluation de la sensibilité à la lévofloxacine des souches isolées d'infections urinaires basses communautaires

Pathologie Biologie

Volumn 53, Issue 2, 2005, Pages 125-128

  Weber, P ^a   Dib, C ^b   Durand, C ^a   Moniot Ville, N ^b  

^a Lab de Biologie Medicale BIO VSM   (France)

^b SANOFI   (France)

Author keywords

Escherichia coli; In vitro; Infection urinaire; L vofloxacine

Indexed keywords

AGAR; AMOXICILLIN; CEFIXIME; COTRIMOXAZOLE; LEVOFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; URINARY TRACT ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; COMMUNITY; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MEDICAL SOCIETY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT; PREVALENCE; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; SHORT COURSE THERAPY; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; BACTERIAL INFECTION; COMMUNICABLE DISEASE; ENTEROBACTER INFECTION; MICROBIOLOGICAL EXAMINATION;

ANTI-INFECTIVE AGENTS, URINARY; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTIONS;

EID: 16244402290     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.03.015     Document Type: Article

References (9)

1. o 40):1996;26-42
2. Weber Ph., Plaisance J.J., Mancy C. Épidémiologie comparée de la résistance aux fluoroquinolones chez les Enterobacteriaceae, Staphylococcus et Pseudomonas aeruginosa en médecine de ville. Presse Med. 24:1995;979-982
3. De Mouy D., Berges J.L., Bouilloux J.P., Charbit N., Fisher I., Grobost F., Larribet Porcher T. Sensibilité à la fosfomycine des principales bactéries issues d'infections urinaires observées en pratique de ville chez les femmes de 15 à 65 ans. Méd Mal Infect. 27:1997;903-906
4. Goldstein F.W. the Multicenter Study Group. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur J Clin Microbiol Infect Dis. 19:2000;112-117
5. Arzouni J.P., Bouilloux J.P., De Moüy D., Fleutiaux S., Galinier J., Gayon A., et al. Les infections urinaires chez la femme de 15 à 65 ans en pratique de ville : surveillance de la sensibilité de Escherichia coli à la fosfomycine trométamol en fonction des antécé dents. Med Mal Infect. 30:2000;699-702
6. Comité de l'antibiogramme de la Société française de microbiologie : communiqué 2002.
7. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother. 51:2003;69-76
8. Fluit A.C., Jones M.E., Schmitz F.J., Acar J., Gupta R., Verhoef J. the Sentry participants group. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the Sentry antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis. 2000;454-460
9. Drago L., De Vecchi E., Mombelli B., Nicola L., Valli M., Gismondo M.R. Activity of levofloxacin and ciprofloxacin against urinary pathogens. J Antimicrob Chemother. 48:2001;37-45